CALL US

Webinars

Learn anytime, anywhere with Schulman’s webinars.

Each month, Schulman’s webinar series connects attendees with IRB experts and industry thought leaders to share regulatory insights and best practices.

Schulman IRB Webinars

  • Convenient web-based format
  • No cost for attendance
  • Robust Q&A with webinar presenter
  • Online archive of all recorded webinars

Schulman WebinarsSchulman is committed to sharing our experience and expertise with the research community, promoting professional development, discussion and collaboration.

Webinar presentations offer expert content on a variety of IRB-related topics, including industry trends, regulatory details and IRB processes.

Schulman’s webinars are a great way to support existing training programs. Certificates of attendance are available for each live presentation. The webinars may be eligible for continuing education credits—check with your individual certifying organization for more information.

Establishing a NIH-Funded Central IRB: The NIH StrokeNet Experience

In this webinar, Michael Linke, IRB Chair at the University of Cincinnati, describes the experience of establishing the NIH StrokeNet Central IRB.

READ MORE

Meeting the Challenge of Device Studies

In this webinar, Robert Romanchuk, IRB Vice Chair at Schulman IRB, discusses the important differences and practical ways to meet the challenges device studies present, meeting the needs of the novice and the expert.

READ MORE

Evolution of Ethics and Regulation of Research Involving Humans

Ernest Prentice, Institutional Official at the University of Nebraska Medical Center, reviews the evolution of ethics & regulation in human research.

READ MORE

Expanded Access Part 2

Rebecca Rogers, IRB Chair at Schulman IRB, discusses expanded access for intermediate and large patient populations and early/expanded access of devices.

READ MORE

Expanded Access Part 1

Rebecca Rogers, IRB Chair at Schulman IRB, discusses expanded access for individual patient use and “Right to Try” legislation.

READ MORE

The Complaint Department

James MacFarlane, HRPP Director, University of New Mexico presents best practices for dealing with complaints, questions and concerns of study participants.

READ MORE

Preparing for the Next Epidemic

Bruce Gordon of University of Nebraska Medical Center and Michelle Roth-Cline, US FDA teach us important lessons learned from the Ebola epidemic.

READ MORE

Local and Central IRB Partnerships

Fred Hamilton, JD, Vice President, Ethics and Compliance at Mount Sinai Medical Center of Florida presents local and central IRB partnerships.

READ MORE

Protecting Vulnerable Subjects

Rob Romanchuk, IRB Member, presents protecting vulnerable subjects.

READ MORE

IRB Review of Recruitment Materials

Kim Looney and Ashley Dixon, IRB Members, Schulman Associates IRB present how to engage subjects responsibly and ethically.

READ MORE

IRB Review of Minimal Risk Research

Michelle Coughlin, MS, IRB Vice Chairperson, Schulman Associates IRB presents IRB review of minimal risk research.

READ MORE

Working with Outsourced IRBs

Karen Christianson of HRP Consulting Group and Bette Bayne of Schulman Associates IRB present working with outsourced IRBs.

READ MORE

Recruitment and Remuneration of Phase I Subjects

Theresa Cummings RN, MS, Vice Chairperson, Schulman Associates IRB presents recruitment and remuneration of phase I subjects.

READ MORE

Elements of Informed Consent

James MacFarlane, Director of Board Services presents what and IRB considers when reviewing informed consent materials.

READ MORE

Reporting to the IRB Part 2

James MacFarlane, Director of Board Services presents frequently asked questions when reporting to the IRB.

READ MORE

Research Impacts of the HIPAA Omnibus Final Rule

Fred Hamilton, JD, Vice President, Ethics and Compliance at Mount Sinai Medical Center of Florida present research impacts of the HIPAA Omnibus final rule.

READ MORE

Protecting Phase I Subjects

Julie Blasingim, Director of Operations, Clinical Pharmacology present IRB considerations for Phase I review of research.

READ MORE

Reporting to the IRB Part 1

James MacFarlane, Director of Board Operations presents how to report the essentials and improve the protections of human subjects.

READ MORE